UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults

Human vaccines & immunotherapeutics, 2021-05, Vol.17 (5), p.1248-1261

2021

Link zum Volltext

Verfügbarkeit prüfen

Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination

Nature communications, 2016-01, Vol.7 (1), p.10369-10369, Article 10369

2016

Link zum Volltext

Verfügbarkeit prüfen

Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial

The Lancet infectious diseases, 2016-08, Vol.16 (8), p.915-922

2016

Link zum Volltext

Verfügbarkeit prüfen

Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

The Journal of infectious diseases, 2009-03, Vol.199 (6), p.805-814

2009

Link zum Volltext

Verfügbarkeit prüfen

Quantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lining fluid of healthy adults

Biomedicine & pharmacotherapy, 2023-12, Vol.169, p.115851-115851, Article 115851

2023

Link zum Volltext

Verfügbarkeit prüfen

Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C

Journal of magnetic resonance imaging, 2011-10, Vol.34 (4), p.947-955

2011

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults

Vaccine, 2023-10, Vol.41 (44), p.6488-6501

2023

Link zum Volltext

Verfügbarkeit prüfen

Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis

EBioMedicine, 2021-11, Vol.73, p.103651-103651, Article 103651

2021

Link zum Volltext

Verfügbarkeit prüfen

Replicate Testing of Clinical Endpoints Can Prevent No-Go Decisions for Beneficial Vaccines

Vaccines (Basel), 2023-09, Vol.11 (9), p.1501

2023

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1 Randomized, Double‐Blind, Placebo‐Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK‐1654 in Healthy Adults

Clinical pharmacology in drug development, 2021-05, Vol.10 (5), p.556-566

2021

Link zum Volltext

Verfügbarkeit prüfen

Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis

PloS one, 2015-06, Vol.10 (6), p.e0129022-e0129022

2015

Link zum Volltext

Verfügbarkeit prüfen

Early Clinical Detection of Pharmacologic Response in Insulin Action in a Nondiabetic Insulin-Resistant Population

Current therapeutic research, 2015-12, Vol.77 (C), p.83-89

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine in a sexually active population of North American women

American journal of obstetrics and gynecology, 2008-03, Vol.198 (3), p.261.e1-261.e11

2008

Link zum Volltext

Verfügbarkeit prüfen

Repeatability of edited lactate and other metabolites in astrocytoma at 3T

Journal of magnetic resonance imaging, 2012-08, Vol.36 (2), p.468-475

2012

Link zum Volltext

Verfügbarkeit prüfen

Noninferiority of Antibody Response to Human Papillomavirus Type 16 in Subjects Vaccinated with Monovalent and Quadrivalent L1 Virus-Like Particle Vaccines

Clinical and Vaccine Immunology, 2007-06, Vol.14 (6), p.792-795

2007

Link zum Volltext

Verfügbarkeit prüfen

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

The New England journal of medicine, 2007-05, Vol.356 (19), p.1928-1943

2007

Link zum Volltext

Verfügbarkeit prüfen

Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile Infection

Clinical infectious diseases, 2020-06, Vol.71 (1), p.81-86

2020

Link zum Volltext

Verfügbarkeit prüfen

Minimum risk weights for comparing treatments in stratified binomial trials

Statistics in medicine, 2000-03, Vol.19 (6), p.811-825

2000

Link zum Volltext

Verfügbarkeit prüfen

“In‐House” Data on the Outside—A Mobile Health Approach

Clinical pharmacology and therapeutics, 2020-04, Vol.107 (4), p.948-956

2020

Link zum Volltext

Verfügbarkeit prüfen

Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging

Journal of magnetic resonance imaging, 2013-06, Vol.37 (6), p.1359-1370

2013

Link zum Volltext

Verfügbarkeit prüfen

Blood Aspergillus RNA is a promising alternative biomarker for invasive aspergillosis

Medical mycology (Oxford), 2016-11, Vol.54 (8), p.801-807

2016

Link zum Volltext

Verfügbarkeit prüfen

Bayesian methods for the design and analysis of noninferiority trials

Journal of biopharmaceutical statistics, 2016-09, Vol.26 (5), p.823-841

2016

Link zum Volltext

Verfügbarkeit prüfen

Fine‐Needle Aspiration for the Evaluation of Hepatic Pharmacokinetics of Vaniprevir: A Randomized Trial in Patients With Hepatitis C Virus Infection

Clinical pharmacology and therapeutics, 2020-06, Vol.107 (6), p.1325-1333

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(42)
Dissertationen
(1)

Sprache

Englisch
(43)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(30)
Humans
(26)
Female
(20)
Adult
(18)
Adolescent
(11)
Middle Aged
(11)
Double-Blind Method
(9)
Immunology
(9)
Medicine, Research & Experimental
(9)
Research & Experimental Medicine
(9)
Infectious Diseases
(8)
Male
(8)
Papillomavirus Infections - Prevention & Control
(8)
Aged
(7)
Biological And Medical Sciences
(7)
Vaccines
(7)
Young Adult
(7)
Human Papillomavirus
(6)
Microbiology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults

Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination

Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial

Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

Quantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lining fluid of healthy adults

Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C

Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults

Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis

Replicate Testing of Clinical Endpoints Can Prevent No-Go Decisions for Beneficial Vaccines

A Phase 1 Randomized, Double‐Blind, Placebo‐Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK‐1654 in Healthy Adults

Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis

Early Clinical Detection of Pharmacologic Response in Insulin Action in a Nondiabetic Insulin-Resistant Population

Impact of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine in a sexually active population of North American women

Repeatability of edited lactate and other metabolites in astrocytoma at 3T

Noninferiority of Antibody Response to Human Papillomavirus Type 16 in Subjects Vaccinated with Monovalent and Quadrivalent L1 Virus-Like Particle Vaccines

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile Infection

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Minimum risk weights for comparing treatments in stratified binomial trials

“In‐House” Data on the Outside—A Mobile Health Approach

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging

Blood Aspergillus RNA is a promising alternative biomarker for invasive aspergillosis

Bayesian methods for the design and analysis of noninferiority trials

Fine‐Needle Aspiration for the Evaluation of Hepatic Pharmacokinetics of Vaniprevir: A Randomized Trial in Patients With Hepatitis C Virus Infection

Suchergebnisse filtern